Whether nonalcoholic fatty liver disease (NAFLD) can predict atherosclerosis in obese patients remains unclear. The aim of our study was to investigate the usefulness of NAFLD and other cardiometabolic parameters in predicting subclinical atherosclerosis in obese patients.

Puig, J., Blasco, G., Daunis I. Estadella, J., Loshuertos, E., Codina, J., Cuba, V., et al. (2014). Nonalcoholic fatty liver disease and age are strong indicators for atherosclerosis in morbid obesity. CLINICAL ENDOCRINOLOGY, 83(2), 180-186 [10.1111/cen.12698].

Nonalcoholic fatty liver disease and age are strong indicators for atherosclerosis in morbid obesity

FEDERICI, MASSIMO;
2014-12-16

Abstract

Whether nonalcoholic fatty liver disease (NAFLD) can predict atherosclerosis in obese patients remains unclear. The aim of our study was to investigate the usefulness of NAFLD and other cardiometabolic parameters in predicting subclinical atherosclerosis in obese patients.
16-dic-2014
Pubblicato
Rilevanza internazionale
Articolo
Esperti anonimi
Settore MED/49 - SCIENZE TECNICHE DIETETICHE APPLICATE
English
Puig, J., Blasco, G., Daunis I. Estadella, J., Loshuertos, E., Codina, J., Cuba, V., et al. (2014). Nonalcoholic fatty liver disease and age are strong indicators for atherosclerosis in morbid obesity. CLINICAL ENDOCRINOLOGY, 83(2), 180-186 [10.1111/cen.12698].
Puig, J; Blasco, G; Daunis I. Estadella, J; Loshuertos, E; Codina, J; Cuba, V; Ortiz, R; Xifra, G; Ricart, W; Pedraza, S; Federici, M; Fernández Real, J
Articolo su rivista
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2108/113079
Citazioni
  • ???jsp.display-item.citation.pmc??? 5
  • Scopus 18
  • ???jsp.display-item.citation.isi??? 15
social impact